MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30

Management to host investor conference call and webcast at 4:30pm ET on that day

PHOENIX, March 16, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022 on Thursday, March 30, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Call and webcast details:

Thursday, March 30, 2023 @ 4:30pm ET

Investor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)
Conference ID: 13736400
To access the Call me™ feature, which avoids having to wait for an operator, click here.

The live audio webcast can be accessed by registering online on the “Investor Relations” section of MedAvail’s website at: The webcast will be archived and available for replay after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology company, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at


Investor Relations 
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors 
[email protected]

SOURCE MedAvail Holdings, Inc.